[1]
“Expression of Glioblastoma Molecular Markers and Sensitivity to Innate Immune Peptides LL-37 and Protegrin-1 as Predictors of Chemotherapy Response”, LJMHR, vol. 26, no. 2, pp. 15–25, Feb. 2026, Accessed: Apr. 04, 2026. [Online]. Available: https://journalspress.uk/index.php/LJMHR/article/view/1776